Skip to content
Menu

Lake Street Maintains Buy on Insight Molecular, Lowers Price Target to $9

Benzinga Newsdesk 9 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Lake Street analyst Thomas Flaten maintains Insight Molecular (NASDAQ:IMDX) with a Buy and lowers the price target from $12 to $9.

Lake Street analyst Thomas Flaten maintains Insight Molecular (NASDAQ:IMDX) with a Buy and lowers the price target from $12 to $9.

Read at benzinga.com

← All stock news